- Home
- IMTE vs TCBP Comparison
IMTE vs TCBP Comparison
Compare IMTE & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- TCBP
- Stock Information
- Founded
- IMTE 2008
- TCBP 2013
- Country
- IMTE Malaysia
- TCBP United Kingdom
- Employees
- IMTE N/A
- TCBP N/A
- Industry
- IMTE Consumer Electronics/Appliances
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMTE Consumer Staples
- TCBP Health Care
- Exchange
- IMTE Nasdaq
- TCBP Nasdaq
- Market Cap
- IMTE 2.6M
- TCBP 3.0M
- IPO Year
- IMTE N/A
- TCBP 2022
- Fundamental
- Price
- IMTE $1.18
- TCBP $5.12
- Analyst Decision
- IMTE
- TCBP
- Analyst Count
- IMTE 0
- TCBP 0
- Target Price
- IMTE N/A
- TCBP N/A
- AVG Volume (30 Days)
- IMTE 3.9K
- TCBP 190.4K
- Earning Date
- IMTE 10-22-2024
- TCBP 11-09-2024
- Dividend Yield
- IMTE N/A
- TCBP N/A
- EPS Growth
- IMTE N/A
- TCBP N/A
- EPS
- IMTE N/A
- TCBP N/A
- Revenue
- IMTE N/A
- TCBP N/A
- Revenue This Year
- IMTE N/A
- TCBP N/A
- Revenue Next Year
- IMTE N/A
- TCBP N/A
- P/E Ratio
- IMTE N/A
- TCBP N/A
- Revenue Growth
- IMTE 174.26
- TCBP N/A
- 52 Week Low
- IMTE $1.02
- TCBP $2.11
- 52 Week High
- IMTE $4.57
- TCBP $1,140.00
- Technical
- Relative Strength Index (RSI)
- IMTE 43.58
- TCBP 44.64
- Support Level
- IMTE $1.17
- TCBP $4.91
- Resistance Level
- IMTE $1.38
- TCBP $5.33
- Average True Range (ATR)
- IMTE 0.09
- TCBP 0.73
- MACD
- IMTE 0.00
- TCBP -0.09
- Stochastic Oscillator
- IMTE 37.50
- TCBP 9.81
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the development, sale and distribution of autostereoscopic 3D displays, conversion equipment, software and technology solutions, and others, Sales of air-filter products, provision of consultancy services, and Sales of Halal products.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.